Prognostic Impact of YKL-40 Immunohistochemical Expression in Patients with Colorectal Cancer

Prognostic Impact of YKL-40 Immunohistochemical Expression in Patients with Colorectal Cancer

This study aims to examine the clinicopathological and prognostic significance of the YKL-40 immunohistochemical expression of tumor and immune cells through human colorectal cancer (CRC) tissue. We performed immunohistochemistry for YKL-40 and investigated the clinicopathological and prognostic imp...

Full description

Bibliographic Details
Main Authors:	Il Hwan Oh, Jung-Soo Pyo, Byoung Kwan Son
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Current Oncology
Subjects:	colorectal cancer YKL-40 immunohistochemistry immunoscore prognosis
Online Access:	https://www.mdpi.com/1718-7729/28/4/274

Similar Items

YKL-40 in high-grade glioma: Prognostic value of protein versus mRNA expression
by: Yu-Hang Zhao, et al.
Published: (2018-01-01)

Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension
by: Dong Wang, et al.
Published: (2012-03-01)

Strong YKL-40 expression in the invasive tumor front of colorectal cancer–A pilot study
by: Maria Kazakova, et al.
Published: (2024-03-01)

Upregulation of YKL-40 Promotes Metastatic Phenotype and Correlates with Poor Prognosis and Therapy Response in Patients with Colorectal Cancer
by: Mariangela De Robertis, et al.
Published: (2022-11-01)

A Comparative Study Of Lamps And Ykl-40 Tissue Expression In Glial Tumors
by: Kazakova Maria Hr., et al.
Published: (2014-09-01)

YKL-40 IN SERA OF BREAST TUMOR PATIENTS
by: Maria Kazakova, et al.
Published: (2010-07-01)

YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer’s Disease
by: Ioannis Mavroudis, et al.
Published: (2021-12-01)

YKL-40 and cytokines - a New Diagnostic Constellation in Rheumatoid Arthritis?
by: Kazakova Maria H., et al.
Published: (2017-03-01)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
by: Camilla Bjørnbak Holst, et al.
Published: (2020-04-01)

Gestasyonel Diyabetes Mellituslu Gebelerde Serum YKL-40 Düzeyi
by: Mahmut Oncul, et al.
Published: (2022-03-01)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
by: Maria Gevezova, et al.
Published: (2023-11-01)

A novel biomarker in acute cholecystitis: YKL-40
by: Eray Çeliktürk, et al.
Published: (2023-04-01)

SERUM YKL-40 LEVELS IN CHRONIC HEART FAILURE.
by: Maria Kazakova, et al.
Published: (2014-06-01)

Overexpression of chitinase like protein YKL-40 in leukemia patients
by: Anil K. Hurmale, et al.
Published: (2013-01-01)

Is YKL-40 (CHI3-L1) a new possible biomarker prognosticator in high grade glioma?
by: A. Oslobanu, et al.
Published: (2015-09-01)

Serum YKL-40 levels and disease characteristics in patients with rheumatoid arthritis
by: Mohammad Reza Jafari-Nakhjavani, et al.
Published: (2019-01-01)

YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children
by: Xingge Yang, et al.
Published: (2018-12-01)

Do Elevated YKL-40 Levels Drive the Immunosuppressive Tumor Microenvironment in Colorectal Cancer? Assessment of the Association of the Expression of YKL-40, MMP-8, IL17A, and PD-L1 with Coexisting Type 2 Diabetes, Obesity, and Active Smoking
by: Błażej Ochman, et al.
Published: (2023-03-01)

YKL-40 – A NEW DIAGNOSTIC BIOMARCER FOR BENIGN BREAST DISEASES AND BREAST CANCER
by: Vanya Uzunova, et al.
Published: (2010-07-01)

Conserved YKL-40 changes in mice and humans after postoperative delirium
by: Jennifer David-Bercholz, et al.
Published: (2022-12-01)

Serum YKL-40 is associated with the severity of coronary artery disease and hypertension
by: Yu Xing, et al.
Published: (2020-11-01)

YKL-40 Aggravates Early-Stage Atherosclerosis by Inhibiting Macrophage Apoptosis in an Aven-dependent Way
by: Wei Huan, et al.
Published: (2021-12-01)

The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review
by: Tong X, et al.
Published: (2018-01-01)

Study of serum YKL-40 in children with bronchial
by: Iman A. Mohammed, et al.
Published: (2016-03-01)

Prognostic Implications of Intratumoral and Peritumoral Infiltrating Lymphocytes in Pancreatic Ductal Adenocarcinoma
by: Jung-Soo Pyo, et al.
Published: (2021-11-01)

Cerebrospinal fluid YKL‐40 level evolution is associated with autoimmune encephalitis remission
by: Guillaume Dorcet, et al.
Published: (2023-01-01)

Evaluation of pleural fluid YKL-40 as a marker of malignant pleural effusion
by: Adel Attia, et al.
Published: (2015-04-01)

YKL-40 Gene Expression and Plasma Levels of CD30 are not Affected by Isoflurane or Propofol: Pilot Study
by: Shirin Lak, et al.
Published: (2016-10-01)

Insulin treatment corrects hepcidin but not YKL-40 levels in persons with type 2 diabetes mellitus matched by body mass index, waist-to-height ratio, C-reactive protein and Creatinine
by: Driton Vela, et al.
Published: (2017-08-01)

Prognostic Implications of Intratumoral Budding in Colorectal Cancer: Detailed Analysis Based on Tumor-Infiltrating Lymphocytes
by: Jung-Soo Pyo, et al.
Published: (2023-12-01)

The value of YKL-40 in ischemic heart disease patients
by: Doaa S.E Zaky, et al.
Published: (2016-01-01)

YKL-40 promotes invasion and metastasis of bladder cancer by regulating epithelial mesenchymal transition
by: Hailong Hao, et al.
Published: (2021-01-01)

Elevation in circulating YKL-40 concentration in patients with cerebrovascular disease
by: Xue Xu, et al.
Published: (2014-08-01)

Serum YKL-40 as a potential biomarker of inflammation in psoriasis
by: Anna Baran, et al.
Published: (2018-01-01)

Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies
by: Bingxian Bian, et al.
Published: (2019-10-01)

Evaluation of the Effect of Oral Isotretinoin on the Level of Serum YKL40 in Acne Vulgaris Patients: A Cross-Sectional Case-Control
by: Ali MA, et al.
Published: (2023-11-01)

Estimation of YKL-40 acute-phase protein in serum of patients with periodontal disease and healthy individuals: A clinical-biochemical study
by: Vinay Chavan, et al.
Published: (2019-01-01)

Comparative effects of oral hypoglycemic drugs on serum YKL-40 level in type 2 diabetic patients.
by: Caterine N. Matta*, et al.
Published: (2020-07-01)

Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
by: Linn Hermansson, et al.
Published: (2019-01-01)

YKL-40 as a possible marker of neutrophilic asthma
by: Krzysztof Specjalski, et al.
Published: (2023-02-01)